QSAR modeling of antiradical and antioxidant activities of flavonoids using electrotopological state (E-State) atom parameters

• Autorzy: Supratim Ray , Chandana Sengupta , Kunal Roy
• Języki publikacji: EN

Abstrakty

EN

In the present paper QSAR modeling using electrotopological state atom (E-state) parameters has been attempted to determine the antiradical and the antioxidant activities of flavonoids in two model systems reported by Burda et al. (2001). The antiradical property of a methanolic solution of 1, 1-diphenyl-2-picrylhydrazyl (DPPH) and the antioxidant activity of flavonoids in a β-carotenelinoleic acid were the two model systems studied. Different statistical tools used in this communication are stepwise regression analysis, multiple linear regressions with factor analysis as the preprocessing step for variable selection (FA-MLR) and partial least squares analysis (PLS). In both the activities the best equation is obtained from stepwise regression analysis, considering, both equation statistics and predictive ability (antiradical activity: R 2 = 0.927, Q2 = 0.871 and antioxidant activity: R 2 = 0.901, Q2 = 0.841). [...]

Słowa kluczowe

EN

Flavonoids; antioxidant; QSAR

• Czasopismo: Open Chemistry
• Rocznik: 2007
• Tom: 5
• Numer: 4
• Strony: 1094-1113

Daty

wydano

2007-12-01

online

2007-09-12

Twórcy

autor

Supratim Ray

• Drug Theoretics & Cheminformatics Lab, Division of Medicinal & Pharmaceutical Chemistry, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700 032, India

autor

Chandana Sengupta

• Drug Theoretics & Cheminformatics Lab, Division of Medicinal & Pharmaceutical Chemistry, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700 032, India

autor

Kunal Roy

• Drug Theoretics & Cheminformatics Lab, Division of Medicinal & Pharmaceutical Chemistry, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700 032, India,

Bibliografia

• [1] G.D. Carlo, N. Mascolo, A.A. Izzo and F. Capasso: “Flavonoid: old and new aspects of a class of natural therapeutic drugs”, Life Sci., Vol. 65, (1999), pp. 337–353. http://dx.doi.org/10.1016/S0024-3205(99)00120-4[Crossref]
• [2] P.C.H. Haollman and I.C.W. Arts: “Flavonols, flavones and flavanols-nature, occurrence and dietary burden”, J. Sci. Food Agric., Vol. 80, (2000), pp. 1081–1093. http://dx.doi.org/10.1002/(SICI)1097-0010(20000515)80:7<1081::AID-JSFA566>3.0.CO;2-G[Crossref]
• [3] S.A. Aherne and N.M. O’Brien: “Dietary Flavonols: Chemistry, Food Content, and Metabolism”, Nutrition, Vol. 18, (2002), pp. 75–81. http://dx.doi.org/10.1016/S0899-9007(01)00695-5[Crossref]
• [4] J.B. Harborne: The Flavonoids, Advances in Research Since 1986, Chapman and Hall, London, 1994.
• [5] O.P. Agarwal: “The anti-inflammatory action of nepitrin, a flavonoid”, Agents Actions, Vol. 12, (1982), pp. 298–302. http://dx.doi.org/10.1007/BF01965393[Crossref]
• [6] M.K. Church: “Cromoglycate-like anti-allergic drugs: a review”, Drugs Today, Vol. 14, (1978), pp. 281–341.
• [7] B F Rasulev, N D Abdullaev, Vladimir N Syrov and J Leszczynski: “A quantitative structure-activity relationship (QSAR) study of the antioxidant activity of flavonoids”, QSAR & Comb. Sci, Vol. 24, (2005), pp. 1056–1065. http://dx.doi.org/10.1002/qsar.200430013[Crossref]
• [8] T. Ozawa: “Genetic and functional changes in mitochondria associated with aging”, Physiol. Rev., Vol. 77, (1997), pp. 425–464.
• [9] S. Luangaram, U. Kukongviriyapan, P. Pakdeechote, V. Kukongviriyapan and P. Pannangpetch: “Protective effects of quercetin against phenylhydrazine-induced vascular dysfunction and oxidative stress in rats”, Food Chem. Toxicol., Vol. 45, (2007), pp. 448–455. http://dx.doi.org/10.1016/j.fct.2006.09.008[Crossref]
• [10] S. Chaudhuri, A. Banerjee, K. Basu, B. Sengupta and P.K. Sengupta: “Interaction of flavonoids with red blood cell membrane lipids and proteins: Antioxidant and antihemolytic effects”, Int. J. Biol. Macromol., Vol. 41, (2007), pp. 42–48. http://dx.doi.org/10.1016/j.ijbiomac.2006.12.003[Crossref]
• [11] A.L. Miller: “Antioxidant flavonoids: structure, function and clinical usage”, Alt. Med. Rev., Vol. 1, (1996), pp. 103–111.
• [12] N.C. Cook and S. Samman: “Flavonoids-chemistry, metabolism, cardioprotective effects, and dietary sources”, J. Nutr. Biochem., Vol. 7, (1996), pp. 66–76. http://dx.doi.org/10.1016/0955-2863(95)00168-9[Crossref]
• [13] E. Middleton: “Biological properties of plant flavonoids: An overview”, Int. J. Pharmacog., Vol. 34, (1996), pp. 344–348.
• [14] O. Farkas, J. Jakus and K. Heberger: “Quantitative structure-activity relationships of flavonoid compounds”, Molecules, Vol. 9, (2004), pp. 1079–1088. http://dx.doi.org/10.3390/91201079[Crossref]
• [15] A.I. Khlebnikov, I.A. Schepetkin, N.G. Domina, L.N. Kirpotina and M.T. Quinn: “Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic and cellular systems”, Bioorg. Med. Chem., Vol. 15, (2007), pp. 1749–1770. http://dx.doi.org/10.1016/j.bmc.2006.11.037[Crossref]
• [16] A. Thakur, S. Vishwakarma and M. Thakur: “QSAR study of flavonoid derivatives as p561ck tyrosinkinase inhibitors”, Bioorg. Med. Chem., Vol. 12, (2004), pp. 1209–1214. http://dx.doi.org/10.1016/j.bmc.2003.11.024
• [17] R. Badhan and J. Penny: “In silico modeling of the interaction of flavonoids with human P-glycoprotein nucleotide-binding domain”, Eur. J. Med. Chem., Vol. 41, (2006), pp. 285–295. http://dx.doi.org/10.1016/j.ejmech.2005.11.012[Crossref]
• [18] A. Karawajczyk, V. Drgan, N. Medic, G. Oboh, S. Passamonti and M. Novic: “Properties of flavonoids influencing the binding of bilitranslocase investigated by neural network modeling”, Biochem. Pharmacol., Vol. 73, (2007), pp. 308–320. http://dx.doi.org/10.1016/j.bcp.2006.09.024[Crossref]
• [19] J. Lameira, C.N. Alves, V. Moliner and E. Silla: “A density functional study of flavonoid compounds with anti-HIV activity”, Eur. J. Med. Chem., Vol. 41, (2006), pp. 616–623. http://dx.doi.org/10.1016/j.ejmech.2006.01.008[Crossref]
• [20] S. Zhang, X. Yang, R.A. Coburn and M.E. Morris: “Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein”, Biochem. Pharmacol., Vol. 70, (2005), pp. 627–639. http://dx.doi.org/10.1016/j.bcp.2005.05.017[Crossref]
• [21] C.N. Alves, J.C. Pinheiro, A.J. Camargo, M.M.C. Ferreira, R.A.F. Romero and A.B.F. da Silva: “A multiple linear regression and partial least squares study of flavonoid compound with anti-HIV activity”, J. Mol. Struct., Vol. 541, (2001), pp. 81–88. [Crossref]
• [22] D. Amic, D.D. Amic, D. Beslo and N. Trinajstic: “Structure-radical scavenging activity relationships of flavonoids”, Croat. Chem. Acta, Vol. 76, (2003), pp. 55–61.
• [23] S. Burda and W. Oleszek: “Antioxidant and antiradical activities of flavonoids”, J. Agric. Food Chem., Vol. 49, (2001), pp. 2774–2779. http://dx.doi.org/10.1021/jf001413m[Crossref]
• [24] L.H. Hall, B. Mohney and L.B. Kier: “The Electrotopological State: An Atom Index for QSAR”, Quant. Struct-Act. Rel., Vol. 10, (1991), pp. 43–51. http://dx.doi.org/10.1002/qsar.19910100108[Crossref]
• [25] L.B. Kier and L.H. Hall: “An Electrotopological State Index for Atoms in Molecules”, Pharm. Res., Vol. 7, (1990), pp. 801–807. http://dx.doi.org/10.1023/A:1015952613760[Crossref]
• [26] L.H. Hall, B. Mohney and L.B. Kier: “Comparison of Electrotopological State Indexes with Molecular Orbital Parameters: Inhibition of MAO by Hydrazides”, Quant. Struct-Act. Rel., Vol. 12, (1993), pp. 44–48. http://dx.doi.org/10.1002/qsar.19930120107[Crossref]
• [27] L.B. Kier and L.H. Hall: Advances in Drug Research, Vol. 22, Academic Press, New York, 1992.
• [28] L.B. Kier and L.H. Hall: Molecular Structure Description: The Electrotopological State, Academic Press, San Diego, 1999.
• [29] K. Roy, A.U. De and C. Sengupta: “QSAR with electrotopological state atom index: Antiadrenergic activity of N,N-dimethyl-2-bromo-2-phenylethylamines”, Indian J. Chem., Vol. 38B, (1999), pp. 942–947.
• [30] A. Saha, K. Roy, K. De and C. Sengupta: “QSAR with electrotopological state atom index. Part 3: Receptor binding affinity of estrogens and non-steroidal estrogen analogs”, Indian J. Chem. Soc., Vol. 78 (2001), pp. 92–96.
• [31] K. Roy, D.K. Pal and C. Sengupta: “QSAR of antineoplastics V: Exploration of Receptor Interaction Sites of Antitumor N-(7-Indolyl)benzenesulfonamides Targeting G1 Phase Using Electrotopological State Atom Index”, Drug Des. Discov., Vol. 17, (2001), pp. 207–218.
• [32] K. Roy, A.U. De and C. Sengupta: “QSAR of Human Factor Xa Inhibitor N2-aroylanthranilamides Using Principal Component Factor Analysis”, Drug Des. Discov., Vol. 18, (2002), pp. 23–31. http://dx.doi.org/10.1080/10559610213503
• [33] A. Saha, K. Roy, K. De and C. Sengupta: “QSAR with Electrotopological State Atom Index: Part IV. - Receptor Binding Affinity of Progestagens”, Indian J. Chem., Vol. 41B, (2002), pp. 1268–1275.
• [34] K. Roy, S. Chakraborty and A. Saha: “Exploring Selectivity Requirements for COX-2 vs. COX-1 binding of 3,4-diaryloxazolones using E-state index”, Bioorg. Med. Chem. Lett., Vol. 13, (2003), pp. 3753–3757. http://dx.doi.org/10.1016/j.bmcl.2003.07.002[Crossref]
• [35] K. Roy and J.T. Leonard: “QSAR Modeling of HIV-1 Reverse Transcriptase Inhibitor 2-Amino-6-arylsulfonylbenzonitriles and Congeners Using Molecular Connectivity and E-State Parameters”, Bioorg. Med. Chem., Vol. 12, (2004), pp. 745–754. http://dx.doi.org/10.1016/j.bmc.2003.11.009
• [36] S. Chakraborty, C. Sengupta and K. Roy: “Exploring QSAR with E-state index: Selectivity Requirements for COX-2 versus COX-1 Binding of Terphenyl Methyl Sulfones and Sulfonamides”, Bioorg. Med. Chem. Lett., Vol. 14, (2004), pp. 4665–4670. http://dx.doi.org/10.1016/j.bmcl.2004.06.095
• [37] C. Sengupta, J.T. Leonard and K. Roy: “Exploring QSAR of melatonin receptor ligand benzofuran derivatives using E-state index”, Bioorg. Med. Chem. Lett., Vol. 14, (2004), pp. 3435–3439. http://dx.doi.org/10.1016/j.bmcl.2004.04.073[Crossref]
• [38] S.K. Lee, Z.H. Mbwambo, H.S. Chung, L. Luyengi, E.J.C. Games, R.G. Mehta, A.D. Kinghorn and J.M. Pezzuto: “Evaluation of the antioxidant potential of natural products”, Combin. Chem. High Throughput Screen., Vol. 1, (1998), pp. 35–46.
• [39] D.E. Pratt: Phenolic Compounds in Food and Their Effect on Health II: Antioxidants and Cancer Prevention, American Chemical Society, Washington DC, 1992.
• [40] R.B. Darlington: Regression and linear models, McGraw Hill, New York, 1990.
• [41] R. Franke: Theoretical Drug Design Methods, Elsevier, Amsterdam, 1984.
• [42] R. Franke and A. Gruska: “Principal component and factor analysis”, in H. Van de Waterbeemd (Ed): Chemometric Methods in molecular Design (Methods and Principles in Medicinal Chemistry, Vol. 2, R. Manhold, P. Krogsgaard-Larsen and H. Timmerman, Eds), VCH, Weinheim, 1995, pp. 113–126.
• [43] S. Wold: “PLS for multivariate linear modeling” in H. Van de Waterbeemd (Ed): Chemometric Methods in Molecular Design (Methods and Principles in Medicinal Chemistry), VCH, Weinheim, 1995, pp. 195–218.
• [44] Y. Fan, L.M. Shi, K.W. Kohn, Y. Pommier and J.N. Weinstein: “Quantitative structure-antitumor activity relationships of camptothecin analogs: Cluster analysis and genetic algorithm-based studies”, J. Med. Chem., Vol. 44, (2001), pp. 3254–3263. http://dx.doi.org/10.1021/jm0005151[Crossref]
• [45] The GW-BASIC program ELECTRO1 was developed by Kunal Roy and standardized on known data sets.
• [46] SPSS is statistical software of SPSS Inc., IL, USA.
• [47] MINITAB is statistical software of Minitab Inc, USA, http://www.minitab.com.
• [48] G.W. Snedecor and W.G. Cochran: Statistical Methods, Oxford & IBH publishing Co. Pvt. Ltd, NewDelhi, 1967.
• [49] S. Word and L. Eriksson: “Statistical validation of QSAR results”, in H. Van de Waterbeemd (Ed): Chemometric Methods in Molecular Design (Methods and Principles in Medicinal Chemistry), VCH, Weinheim, 1995, pp. 312–318.
• [50] A.K. Debnath: “Quantitative structure-activity relationship (QSAR): A versatile tool in drug design”, in A.K. Ghose and V.N. Viswanadhan (Eds): Combinatorial Library Design and Evaluation: Principles, Software, Tools and Application in Drug Discovery, Marcel Dekker Inc, NewYork, 2001, pp. 73–129.
• [51] J.D. Walker, J. Jaworska, M.H. Comber, T.W. Schultz and J.C. Dearden: “Guidelines for developing and using quantitative structure-activity relationships”, Environ Toxicol. Chem., Vol. 22, (2003), pp. 1653–1665. http://dx.doi.org/10.1897/01-627[Crossref]
• [52] S.A.B.E. Van Acker, M.J. De Groot, D.J. Van Den Berg, M.N.J.L. Tromp, G.D.O. Den Kelder, W.J.F. Van Der Vijgh and A. Bust: “A quantum chemical explanation of the antioxidant activity of flavonoids”, Chem. Res. Toxicol., Vol. 9, (1996), pp. 1305–1312. http://dx.doi.org/10.1021/tx9600964[Crossref]

Identyfikatory

DOI

10.2478/s11532-007-0047-3